2m 2m 2m 2m 2m 2m 2m
ALZAMEND (ALZN)
NASDAQ
$1.57+$0.01 (+0.90%)
Price as of Aug 21, 2026 7:51 PM EDT- $7.5MMarket Cap
- -37.35%1-Year Change
- BiotechnologyIndustry
ALZAMEND (ALZN)
$1.57+$0.01 (+0.90%)
ALZN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.56 | ||
Change | -$0.07 (-4.29%) | ||
Open | $1.57 | ||
High | $1.60 | ||
Low | $1.49 | ||
Previous Close | $1.63 | ||
Volume | 244,126 | ||
30-Day Average Volume | 76,262 | ||
1-Week Change | 0.65% | ||
1-Month Change | 18.18% | ||
1-Year Change | -37.35% | ||
3-Year Change | -99.61% | ||
5-Year Change | -99.96% | ||
Fundamentals | |||
Shares Outstanding | 4.8M | ||
Total Assets | $2.1M | ||
Market Cap | $7.5M | ||
Enterprise Value | $6.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.3M | ||
Free Cash Flow | -$2.8M | ||
EBIT | -$8.3M | ||
EBITDA | -$8.2M | ||
Net Working Capital | $418,345.00 | ||
EPS | -$2.03 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 9 | ||
Last Split Date | 05/12/2025 | ||
Earnings & Revenue